Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus

Plasma B-type natriuretic peptide cannot predict treatment response to ibuprofen in preterm infants with patent ductus arteriosus

Plasma B-type natriuretic peptide (BNP) is a useful marker for diagnosis of hemodynamically significant PDA (hsPDA) and serial BNP measurement is also valuable for monitoring treatment response. This retrospective study was performed to evaluate whether plasma BNP level can predict treatment respons...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2020-03, Vol.10 (1), p.4430-4430, Article 4430
Hauptverfasser: Oh, Seong Hee, Lee, Byong Sop, Jung, Euiseok, Oh, Moon Yeon, Do, Hyun-Jeong, Kim, Ellen Ai-Rhan, Kim, Ki-Soo
Format: Artikel
Sprache:eng
Schlagworte:
692/53/2423
692/700/1720/3186
Birth weight
Brain natriuretic peptide
Congenital diseases
Coronary vessels
Gestational age
Humanities and Social Sciences
Ibuprofen
Infants
multidisciplinary
Newborn babies
Nonsteroidal anti-inflammatory drugs
Peptides
Premature babies
Science
Science (multidisciplinary)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Plasma B-type natriuretic peptide (BNP) is a useful marker for diagnosis of hemodynamically significant PDA (hsPDA) and serial BNP measurement is also valuable for monitoring treatment response. This retrospective study was performed to evaluate whether plasma BNP level can predict treatment response to ibuprofen in preterm infants born at
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-020-61291-w